JPH0656817A - 5-trifluoromethyl-1,3-dioxin-4-one derivative - Google Patents

5-trifluoromethyl-1,3-dioxin-4-one derivative

Info

Publication number
JPH0656817A
JPH0656817A JP3208977A JP20897791A JPH0656817A JP H0656817 A JPH0656817 A JP H0656817A JP 3208977 A JP3208977 A JP 3208977A JP 20897791 A JP20897791 A JP 20897791A JP H0656817 A JPH0656817 A JP H0656817A
Authority
JP
Japan
Prior art keywords
derivative
trifluoromethyl
dioxin
carbon atoms
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3208977A
Other languages
Japanese (ja)
Inventor
Tomoyasu Iwaoka
友保 岩岡
Kiyoshige Ochi
清成 越智
Chikara Kaneko
主税 金子
Masayuki Sato
雅之 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP3208977A priority Critical patent/JPH0656817A/en
Publication of JPH0656817A publication Critical patent/JPH0656817A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

(57)【要約】 [構成] [式中、RおよびRは、同一または異なって炭素数
1〜5のアルキル基、または、一緒になって炭素数3〜
6のアルキレン基を表す。Rは、水素原子または、炭
素数1〜6のアルキル基またはアリール基を表す。]で
示される5−トリフルオロメチル−1,3−ジオキシン
−4−オン誘導体。 [効果] この化合物は、尿素誘導体と反応させること
により、抗腫瘍剤あるいは抗ウイルス剤として有用な5
−トリフルオロメチルウラシル誘導体を高収率で与え
る。また、本発明の化合物は、β−ケト−α−トリフル
オロメチル酢酸誘導体と等価であり、種々のアルコール
類と反応させることにより、医薬及び農薬の中間体とし
て有用なα位にトリフルオロメチル基を有するカルボン
酸誘導体を高収率で与える。
(57) [Summary] [Structure] [In the formula, R 1 and R 2 are the same or different and each is an alkyl group having 1 to 5 carbon atoms, or R 1 and R 2 together are 3 to 3 carbon atoms.
6 represents an alkylene group. R 3 represents a hydrogen atom or an alkyl group or aryl group having 1 to 6 carbon atoms. ] The 5-trifluoromethyl-1,3-dioxin-4-one derivative shown by these. [Effect] This compound is useful as an antitumor agent or antiviral agent by reacting with a urea derivative.
Giving the trifluoromethyluracil derivative in high yield. Further, the compound of the present invention is equivalent to a β-keto-α-trifluoromethylacetic acid derivative, and by reacting with various alcohols, a trifluoromethyl group at the α-position useful as an intermediate for pharmaceuticals and agricultural chemicals is obtained. The carboxylic acid derivative having is provided in high yield.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規な1,3−ジオキ
シノン誘導体に関する。さらに詳しくは、医薬および農
薬等の合成化学上のシントンとして有用な5位にトリフ
ルオロメチル基を有する1,3−ジオキシン−4−オン
誘導体に関する
FIELD OF THE INVENTION The present invention relates to a novel 1,3-dioxynone derivative. More specifically, it relates to a 1,3-dioxin-4-one derivative having a trifluoromethyl group at the 5-position, which is useful as a synthetic chemical synthon for pharmaceuticals and agricultural chemicals.

【0002】[0002]

【従来の技術】1,3−ジオキシン−4−オン誘導体
は、加熱によりアシルケテンを生成する有機化学上種々
の化合物の合成に有用なシントンとなる。アシルケテン
は医薬、農薬の中間体等として有用な化合物であり、種
々の合成に用いられているが、トリフルオロメチル基を
有する化合物は、これまで知られていない。
2. Description of the Related Art 1,3-dioxin-4-one derivatives are useful synthons for the synthesis of various compounds in organic chemistry which produce acyl ketene by heating. Acyl ketene is a compound useful as an intermediate for medicines and agricultural chemicals, and is used in various syntheses, but a compound having a trifluoromethyl group has not been known so far.

【0003】[0003]

【課題を解決するための手段】本発明は、一般式(I)The present invention has the general formula (I)

【化2】 (式中、RおよびRは、同一または異なって炭素数
1〜5のアルキル基、または、一緒になって炭素数3〜
6のアルキレン基を表す。Rは、水素原子または、炭
素数1〜6のアルキル基またはアリール基を表す。)で
示される、5−トリフルオロメチル−1,3−ジオキシ
ン−4−オン誘導体を提供するものである。
[Chemical 2] (In the formula, R 1 and R 2 are the same or different and are an alkyl group having 1 to 5 carbon atoms, or R 1 and R 2 together are 3 to 3 carbon atoms.
6 represents an alkylene group. R 3 represents a hydrogen atom or an alkyl group or aryl group having 1 to 6 carbon atoms. ), Which provides a 5-trifluoromethyl-1,3-dioxin-4-one derivative.

【0004】式(I)で示される化合物は、一般に次の
ような反応により合成することができる。
The compound represented by the formula (I) can be generally synthesized by the following reaction.

【化3】 (上記式中、R、R、Rは前記と同様の意味を示
す。Xは塩素、臭素またはヨウ素等のハロゲン原子を表
す。)
[Chemical 3] (In the above formula, R 1 , R 2 , and R 3 have the same meanings as described above. X represents a halogen atom such as chlorine, bromine, or iodine.)

【0005】式(II)の化合物は、例えば特開昭62
−205075号公報記載の方法等で合成できる。
The compound of the formula (II) is disclosed, for example, in JP-A-62-62.
It can be synthesized by the method described in -205075 Publication.

【0006】この反応でトリフルオロメチル化に用いる
トリフルオロメチル銅は、既知の反応で合成したものを
単離することなく用いる。トリフルオロメチル化は、通
常、不活性な溶媒中で行われる。好ましい溶媒は、ヘキ
サメチルホスホリックトリアミド、ジメチルホルムアミ
ド、ジメチルアセトアミド、ジメチルイミダゾリジノ
ン、N−メチルピロリドン等である。
The trifluoromethyl copper used in the trifluoromethylation in this reaction is used without isolation of the one synthesized in the known reaction. Trifluoromethylation is usually performed in an inert solvent. Preferred solvents are hexamethylphosphoric triamide, dimethylformamide, dimethylacetamide, dimethylimidazolidinone, N-methylpyrrolidone and the like.

【0007】反応温度は、一般には、室温から70℃で
あるが、好ましくは、40〜50℃である。得られた生
成物は、通常の方法、例えば、真空蒸留、再結晶等によ
り精製することができる。
The reaction temperature is generally room temperature to 70 ° C., preferably 40 to 50 ° C. The obtained product can be purified by a conventional method such as vacuum distillation or recrystallization.

【0008】[0008]

【実施例】以下に本発明の実施例を示すが、本発明がこ
れにより限定されるものではない。
EXAMPLES Examples of the present invention will be shown below, but the present invention is not limited thereto.

【実施例1】 4−オキソ−5−トリフルオロメチル−4H−1,3−
ジオキシン−2−スピロシクロヘキサンの製法
Example 1 4-oxo-5-trifluoromethyl-4H-1,3-
Preparation of dioxin-2-spin Russia cyclohexane

【0009】銅粉0.75gとヨードトリフルオロメタ
ン1.80gとヘキサメチルホスホリックトリアミド
(HMPA)5mlを120℃で5時間加熱した混合物
に、5−ヨード−4−オキソ−4H−1,3−ジオキシ
ン−2−スピロシクロヘキサン147mgを加えて、4
5℃で18時間反応した。ついで反応液を水20ml、
エーテル10mlに展開し、不溶物を濾別した。母液を
エーテル10mlで抽出し、有機層を水10mlで2回
洗浄後硫酸マグネシウムで乾燥して、溶媒を留去した。
残査をシリカゲルクロマトグラフィー(ヘキサン:塩化
メチレン=1:1)で精製し、標記化合物75mgを得
た。エーテル−ヘキサンから再結晶し、無色の針状晶を
得た。融点:77.5〜78.0℃
A mixture of 0.75 g of copper powder, 1.80 g of iodotrifluoromethane and 5 ml of hexamethylphosphoric triamide (HMPA) heated at 120 ° C. for 5 hours was added to 5-iodo-4-oxo-4H-1,3. -Add 147 mg of dioxin-2-spirocyclohexane and add 4
The reaction was carried out at 5 ° C for 18 hours. Then, the reaction solution is 20 ml of water,
It was developed in 10 ml of ether and the insoluble matter was filtered off. The mother liquor was extracted with 10 ml of ether, the organic layer was washed twice with 10 ml of water and then dried over magnesium sulfate, and the solvent was distilled off.
The residue was purified by silica gel chromatography (hexane: methylene chloride = 1: 1) to obtain 75 mg of the title compound. Recrystallization from ether-hexane gave colorless needle crystals. Melting point: 77.5 to 78.0 ° C

【0010】IR(CHCl) 2950,1750
and 1645 cm−1 NMR(CDCl)δ:1.3−2.3(10H,
m),7.70(1H,brs). High Resolution MS:C1011
として 236.0660 実測値 236.
0656
IR (CHCl 3 ) 2950, 1750
and 1645 cm -1 NMR (CDCl 3 ) δ: 1.3-2.3 (10H,
m), 7.70 (1H, brs). High Resolution MS: C 10 H 11
F 3 O 3 as 236.0660 Found 236.
0656

【0011】[0011]

【実施例1】6−メチル−4−オキソ−5−トリフルオルメチル−4
H−1,3−ジオキシン−2−スピロシクロヘキサンの
製法
Example 1 6-Methyl-4-oxo-5-trifluoromethyl-4
H-1,3-dioxin-2-spirocyclohexane
Manufacturing method

【0012】銅粉4.57gとヨードトリフルオロメタ
ン8.82gとHMPA18mlを120℃で2時間加
熱した混合物に、5−ヨード−6−メチル−4−オキソ
−4H−1,3−ジオキシン−2−スピロシクロヘキサ
ン1.54gを加え、50℃で3時間反応した。つい
で、反応液を氷水100mlに展開し、飽和炭酸ナトリ
ウム水溶液で中和後、不溶物を濾別した。濾過物をエー
テルで洗浄後、水層とエーテル洗浄液を合わせてエーテ
ル抽出した。有機層を水30mlで2回洗浄後、硫酸マ
グネシウムで乾燥して、溶媒を留去した。残査をシリカ
ゲルクロマトグラフィー(ヘキサン:塩化メチレン=
1:1)で精製し、無色オイル状の標記化合物0.67
gを得た。
A mixture of 4.57 g of copper powder, 8.82 g of iodotrifluoromethane and 18 ml of HMPA heated at 120 ° C. for 2 hours was added to 5-iodo-6-methyl-4-oxo-4H-1,3-dioxin-2-. 1.54 g of spirocyclohexane was added, and the mixture was reacted at 50 ° C. for 3 hours. Next, the reaction solution was developed in 100 ml of ice water, neutralized with a saturated aqueous solution of sodium carbonate, and the insoluble matter was filtered off. The filtered product was washed with ether, and the aqueous layer and the ether washing solution were combined and extracted with ether. The organic layer was washed twice with 30 ml of water and dried over magnesium sulfate, and the solvent was distilled off. The residue was chromatographed on silica gel (hexane: methylene chloride =
1: 1) and the title compound 0.67 as a colorless oil.
g was obtained.

【0013】IR(CHCl) 2960,1740
and 1630cm−1 NMR(CDCl) δ:1.3−2.3(10H,
m),2.27(3H,q,J=2Hz). High Resolution MS:C1113
として 250.0816 実測値 250.
0817
IR (CHCl 3 ) 2960, 1740
and 1630 cm -1 NMR (CDCl 3 ) δ: 1.3-2.3 (10H,
m), 2.27 (3H, q, J = 2Hz). High Resolution MS: C 11 H 13
F 3 O 3 as 250.0816 Found 250.
0817

【0014】[0014]

【実施例3】2,2,6−トリメチル−5−トリフルオルメチル−
1,3−ジオキシン−4−オンの製法
Example 3 2,2,6-Trimethyl-5-trifluoromethyl-
Process for producing 1,3-dioxin-4-one

【0015】銅粉1.37gとヨードトリフルオロメタ
ン2.65gとHMPA5.4mlを115℃で2時間
30分加熱した混合物に、5−ヨード−2,2,6−ト
リメチル−1,3−ジオキシン−4−オン0.40gを
加え、50℃で5時間反応した。ついで反応液を氷水3
0ml、エーテル30mlに展開し、不溶物を濾別し
た。濾過物をエーテルで洗浄後、水層とエーテル洗浄液
を合わせてエーテル抽出した。有機層を水20mlで2
回洗浄後、硫酸マグネシウムで乾燥して、溶媒を留去し
た。残査をシリカゲルクロマトグラフィー(ヘキサン:
酢酸エチル=10:1)で精製し、無色オイル状の標記
化合物0.168gを得た。
A mixture obtained by heating 1.37 g of copper powder, 2.65 g of iodotrifluoromethane and 5.4 ml of HMPA at 115 ° C. for 2 hours and 30 minutes was added to 5-iodo-2,2,6-trimethyl-1,3-dioxin-. 0.40 g of 4-one was added and reacted at 50 ° C. for 5 hours. Then, the reaction solution is ice water 3
It was developed into 0 ml and 30 ml of ether, and the insoluble matter was filtered off. The filtered product was washed with ether, and the aqueous layer and the ether washing solution were combined and extracted with ether. 2 ml of organic layer with 20 ml of water
After washing twice, it was dried over magnesium sulfate and the solvent was distilled off. The residue was chromatographed on silica gel (hexane:
Purification with ethyl acetate = 10: 1) gave 0.168 g of the title compound as a colorless oil.

【0016】IR(CHCl) 1750,1630
and 1400 cm−1 NMR(CDCl)δ:1.73(6H,s),2.
27(3H,m). High Resolution MS:C
として 210.0504 実測値 210.05
43
IR (CHCl 3 ) 1750, 1630
and 1400 cm -1 NMR (CDCl 3 ) δ: 1.73 (6H, s), 2.
27 (3H, m). High Resolution MS: C 8 H 9 F 3
As O 3 , 210.0504 measured value 210.05
43

【0017】[0017]

【実施例4】 2,2−ジメチル−6−フェニル−5−トリフルオロメ
チル−1,3−ジオキシン−4−オンの製法
Example 4 2,2-dimethyl-6-phenyl-5-trifluoromethyl-1,3-Jioki Shin-4-one of formula

【0018】銅粉1.37gとヨードトリフルオロメタ
ン2.65gとHMPA5.4mlを120℃で2時間
30分加熱した混合物に、5−ヨード−2,2−ジメチ
ル−6−フェニル−1,3−ジオキシン−4−オン49
5mgを加え、60℃で2時間反応した。ついで反応液
を氷水30ml、エーテル30mlに展開し、不溶物を
濾別した。濾過物をエーテルで洗浄後、水層とエーテル
洗浄液を合わせてエーテル抽出した。有機層を水20m
lで2回洗浄後、硫酸マグネシウムで乾燥して、溶媒を
留去した。残査をシリカゲルクロマトグラフィー(ヘキ
サン:塩化メチレン=1:1)で精製し、標記化合物2
16mgを得た。酢酸エチル−ヘキサンから再結晶して
無色の針状晶を得た。融点111.5〜112.5℃。
A mixture of 1.37 g of copper powder, 2.65 g of iodotrifluoromethane and 5.4 ml of HMPA heated at 120 ° C. for 2 hours and 30 minutes was added to 5-iodo-2,2-dimethyl-6-phenyl-1,3-. Dioxin-4-one 49
5 mg was added and reacted at 60 ° C. for 2 hours. Then, the reaction solution was developed in 30 ml of ice water and 30 ml of ether, and the insoluble matter was filtered off. The filtered product was washed with ether, and the aqueous layer and the ether washing solution were combined and extracted with ether. The organic layer is 20m
It was washed twice with 1 and dried over magnesium sulfate, and the solvent was distilled off. The residue was purified by silica gel chromatography (hexane: methylene chloride = 1: 1) to give the title compound 2
16 mg was obtained. Recrystallization from ethyl acetate-hexane gave colorless needle crystals. Melting point 111.5-112.5 [deg.] C.

【0019】IR (CHCl) 1740,161
5,1385 and 1375 cm−1 NMR(CDCl)δ:1.87(6H,s),7.
60(5H,s). High Resolution MS:C1311
として272.0660 実測値 272.0
658
IR (CHCl 3 ) 1740, 161
5, 1385 and 1375 cm -1 NMR (CDCl 3 ) δ: 1.87 (6H, s), 7.
60 (5H, s). High Resolution MS: C 13 H 11
272.0660 as F 3 O 3 measured value 272.0
658

【0020】[0020]

【発明の効果】本発明の化合物は、尿素誘導体と反応さ
せることにより、抗腫瘍剤あるいは抗ウイルス剤として
有用な5−トリフルオロメチルウラシル誘導体を高収率
で与える。また、本発明の化合物は、β−ケト−α−ト
リフルオロメチル酢酸誘導体と等価であり、種々のアル
コール類と反応させることにより、医薬及び農薬の中間
体として有用なα位にトリフルオロメチル基を有するカ
ルボン酸誘導体を高収率で与える。
INDUSTRIAL APPLICABILITY By reacting the compound of the present invention with a urea derivative, a 5-trifluoromethyluracil derivative useful as an antitumor agent or antiviral agent is provided in a high yield. Further, the compound of the present invention is equivalent to a β-keto-α-trifluoromethylacetic acid derivative, and by reacting with various alcohols, a trifluoromethyl group at the α-position useful as an intermediate for pharmaceuticals and agricultural chemicals is obtained. The carboxylic acid derivative having is provided in high yield.

【0021】[0021]

【参考例1】1,3−ジメチル−5−トリフルオロメチルウラシルの
合成
Reference Example 1 of 1,3-dimethyl-5-trifluoromethyluracil
Synthesis

【0022】N,N’−ジメチル尿素35.2mgとト
ルエン2mlの溶液に、還流しつつ4−オキソ−5−ト
リフルオロメチル−4H−1,3−ジオキシン−2−ス
ピロシクロヘキサン47.2mgのトルエン溶液2ml
を2時間かけて滴下した。滴下後、さらに30分間還流
し、溶媒を減圧下留去した。残査をシリカゲルクロマト
グラフィー(ヘキサン:酢酸エチル=1:1)で精製
し、標記化合物35mgを得た。酢酸エチル−エーテル
から再結晶して、無色の板状晶を得た。融点:108〜
109℃
To a solution of 35.2 mg N, N'-dimethylurea and 2 ml toluene, under reflux, 4oxo-5-trifluoromethyl-4H-1,3-dioxin-2-spirocyclohexane 47.2 mg toluene. 2 ml of solution
Was added dropwise over 2 hours. After the dropping, the mixture was refluxed for another 30 minutes, and the solvent was distilled off under reduced pressure. The residue was purified by silica gel chromatography (hexane: ethyl acetate = 1: 1) to obtain 35 mg of the title compound. Recrystallization from ethyl acetate-ether gave colorless plate crystals. Melting point: 108-
109 ° C

【0023】IR(CHCl) 1725,1690
and 1680 cm−1 NMR(CDCl)δ: 3.37(3H,s),
3.50(3H,s),7.70(1H,m). High Resolution MS:C
として 208.0460 実測値 208.
0473
IR (CHCl 3 ) 1725,1690
and 1680 cm -1 NMR (CDCl 3 ) δ: 3.37 (3H, s),
3.50 (3H, s), 7.70 (1H, m). High Resolution MS: C 7 H 7 F 3
As N 2 O 2 , 208.0460 Found 208.
0473

【0024】[0024]

【参考例2】(E)−3−ヒドロキシ−2−トリフルオロメチルアク
リル酸ベンジルの合成
Reference Example 2 (E) -3-Hydroxy-2-trifluoromethylac
Synthesis of benzyl phosphate

【0025】4−オキソ−5−トリフルオロメチル−4
H−1,3−ジオキシン−2−スピロシクロヘキサン4
7.2mgとベンジルアルコール22.7mgとトルエ
ン0.5mlを30分間還流後、溶媒と過剰のベンジル
アルコールと副生するシクロヘキサノンを減圧下留去
し、無色オイル状の標記化合物42mgを得た。
4-oxo-5-trifluoromethyl-4
H-1,3-dioxin-2-spirocyclohexane 4
After refluxing 7.2 mg, benzyl alcohol 22.7 mg, and toluene 0.5 ml for 30 minutes, the solvent, excess benzyl alcohol, and by-product cyclohexanone were distilled off under reduced pressure to obtain 42 mg of the title compound as a colorless oil.

【0026】IR(CHCl) 1680,142
0,1190 and 1140 cm−1 NMR(CDCl) δ:5.37(2H,s),
7.40(5H,s),7.76(1H,brd,J=
13Hz),12.35(1H,d,J=13Hz). High Resolution MS:C11
として246.0504 実施値 246.05
12
IR (CHCl 3 ) 1680,142
0,1190 and 1140 cm -1 NMR (CDCl 3 ) δ: 5.37 (2H, s),
7.40 (5H, s), 7.76 (1H, brd, J =
13 Hz), 12.35 (1 H, d, J = 13 Hz). High Resolution MS: C 11 H 9 F
As 3 O 3 246.0504 embodiment Value 246.05
12

【0027】[0027]

【参考例3】3−オキソ−2−トリフルオロメチル酪酸ベンジルの合
[Reference Example 3] Combination of benzyl 3-oxo-2-trifluoromethylbutyrate
Success

【0028】4−オキソ−5−トリフルオロメチル−4
H−1,3−ジオキシン−2−スピロシクロヘキサン5
0mgとベンジルアルコール22.7mgとキシレン
0.5mlを20分間還流後、溶媒と過剰のベンジルア
ルコールと副生するシクロヘキサノンを減圧下留去し、
無色オイル状の標記化合物53mgを得た。
4-oxo-5-trifluoromethyl-4
H-1,3-dioxin-2-spirocyclohexane 5
After refluxing 0 mg, benzyl alcohol 22.7 mg, and xylene 0.5 ml for 20 minutes, the solvent, excess benzyl alcohol, and by-produced cyclohexanone were distilled off under reduced pressure.
53 mg of the title compound was obtained as a colorless oil.

【0029】IR(CHCl) 1760,173
5,1260 and 1160cm−1 NMR(CDCl)δ:2.30(3H,s),4.
23(1Hx0.9,q,J=8Hz),5.27(2
H,s),7.37(5H,s),14.00(1Hx
0.1,s). High Resolution MS:C1211
として260.0660 実測値 260.0
647
IR (CHCl 3 ) 1760,173
5,1260 and 1160 cm -1 NMR (CDCl 3 ) δ: 2.30 (3H, s), 4.
23 (1Hx0.9, q, J = 8Hz), 5.27 (2
H, s), 7.37 (5H, s), 14.00 (1Hx
0.1, s). High Resolution MS: C 12 H 11
260.0660 actual value 260.0 as F 3 O 3
647

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】一般式 (I) 【化1】 (式中、RおよびRは、同一または異なって炭素数
1〜5のアルキル基、または、一緒になって炭素数3〜
6のアルキレン基を表す。Rは、水素原子または、炭
素数1〜6のアルキル基またはアリール基を表す。)で
示される、5−トリフルオロメチル−1,3−ジオキシ
ン−4−オン誘導体。
1. A compound represented by the general formula (I): (In the formula, R 1 and R 2 are the same or different and are an alkyl group having 1 to 5 carbon atoms, or R 1 and R 2 together are 3 to 3 carbon atoms.
6 represents an alkylene group. R 3 represents a hydrogen atom or an alkyl group or aryl group having 1 to 6 carbon atoms. ), A 5-trifluoromethyl-1,3-dioxin-4-one derivative.
JP3208977A 1991-05-16 1991-05-16 5-trifluoromethyl-1,3-dioxin-4-one derivative Pending JPH0656817A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3208977A JPH0656817A (en) 1991-05-16 1991-05-16 5-trifluoromethyl-1,3-dioxin-4-one derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3208977A JPH0656817A (en) 1991-05-16 1991-05-16 5-trifluoromethyl-1,3-dioxin-4-one derivative

Publications (1)

Publication Number Publication Date
JPH0656817A true JPH0656817A (en) 1994-03-01

Family

ID=16565295

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3208977A Pending JPH0656817A (en) 1991-05-16 1991-05-16 5-trifluoromethyl-1,3-dioxin-4-one derivative

Country Status (1)

Country Link
JP (1) JPH0656817A (en)

Similar Documents

Publication Publication Date Title
JP3378315B2 (en) Carbazolone derivative and method for preparing the same
GB2036744A (en) Eburnane derivatives
JP3207018B2 (en) Method for producing benzylsuccinic acid derivative and intermediate for producing the same
JPH08311025A (en) Production of 4-hydroxy-2-pyrrolidone
JPH083143A (en) Process for producing 6-aralkyl-substituted pyrimidine derivative
JPH10130244A (en) Method for producing acyclonucleoside
JP3477631B2 (en) Purification method of 1,3-bis (3-aminopropyl) -1,1,3,3-tetraorganodisiloxane
JP3855686B2 (en) 3,3-dialkoxy-2-hydroxyimino derivative and process for producing the same
JP3420321B2 (en) Method for producing 2,4,5-trihalogeno-3-methylbenzoic acid
KR100856133B1 (en) Improved process for preparing atorvastatin
JP3058399B2 (en) [[4-Substituted acetyl-O-phenylene] dioxy] diacetate derivative and method for producing the same
JPH06340622A (en) Production of benzylsuccinic acid derivative and intermediate for its synthesis
JP2986003B2 (en) 2-Alkyl-3-styryloxiranecarboxylic acid ester and method for producing the same
KR0142140B1 (en) Method for preparing 2-benzoyl-3-aminoacrylate derivative
JP2743198B2 (en) Cyclopentanes
JP3155909B2 (en) Method for producing 1,3-dialkyl-2-imidazolidinones
JPH0124782B2 (en)
JP3013760B2 (en) Method for producing 4-hydroxy-2-pyrrolidone
JP2833672B2 (en) Method for producing β-ketonitrile
JP3632979B6 (en) Method for producing 2-aminomalonic acid derivative and 2-amino-1,3-propanediol derivative
JP2008517967A (en) Process for producing phenyl 2-pyrimidinyl ketones and novel intermediates thereof
JP3632979B2 (en) Method for producing 2-aminomalonic acid derivative and 2-amino-1,3-propanediol derivative
JPH0692958A (en) 5-Fluoro-1,3-dioxin-4-one derivative
JPH0457662B2 (en)
JPH0812658A (en) Production of sydnones